Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer
about
Obesity and cancer risk: recent review and evidenceLinking diet to acne metabolomics, inflammation, and comedogenesis: an updateDoes milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysisFine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.Insulin-like growth factor-1, IGF binding protein-3, and the risk of esophageal cancer in a nested case-control study.Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin.Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.Physical confirmation and mapping of overlapping rat mammary carcinoma susceptibility QTLs, Mcs2 and Mcs6Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survivalGenetic and dietary determinants of insulin-like growth factor (IGF)-1 and IGF binding protein (BP)-3 levels among Chinese women.A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3The role of the insulin-like growth factor-1 system in breast cancerVisceral adiposity, insulin resistance and cancer risk.Identification of somatostatin receptor type 5 gene polymorphisms associated with acromegalyCirculating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.IGFBP3 polymorphisms and risk of esophageal cancer in a Chinese population.Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)Genetic polymorphisms of insulin-like growth factor 1 and insulin-like growth factor binding protein 3, xenoestrogen, phytoestrogen, and premenopausal breast cancerIdentification of breast cancer prognosis markers using integrative sparse boosting.Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk.Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.Genomewide meta-analysis identifies loci associated with IGF-I and IGFBP-3 levels with impact on age-related traits.Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium.Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma riskHeight, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.Insulin-like Growth Factor 1 gene polymorphism and breast cancer risk.Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy.Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.Determinants of dietary supplement use--healthy individuals use dietary supplements.Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy.Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis.Insulin-like growth factor 1 gene polymorphism in women with breast cancer.Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer Survival.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclatureThe association between IGF1 gene rs1520220 polymorphism and cancer susceptibility: a meta-analysis based on 12,884 cases and 58,304 controls
P2860
Q22252595-27AC1AB9-8134-4FB5-ACED-36E533E03CACQ26800264-E073C1B4-6754-4927-A3C2-375C398CB897Q30235013-30F400D5-D5BC-43A7-B102-E32304D33761Q30371049-1D2BC678-C45B-4F29-BD33-204B360EAFD2Q33719968-279D2B88-1DD6-4356-ADAA-D9E9748C9BABQ33801805-66881391-E5DF-42A7-A59F-03759EEBBEACQ33845203-730704A5-A8C7-40C8-90C5-16EE715FFD47Q33916825-8C691082-E19E-410C-B064-35A1B4B6C3C5Q34069086-1560C22D-E607-4573-B069-D3618D525EDBQ34240707-E269299B-69C4-4C99-ABA5-427C188A3D27Q34294117-13D8B52F-7107-49A5-9057-336BF03EE0E3Q34597879-60395CC3-2AD6-4996-9570-0697E89F5002Q35105295-114A6DA5-B8B1-487F-AD3B-1DA0FB78EC53Q35133640-A32050F4-90EA-483A-8BDA-EC47E8ACB78CQ35228807-2BDC72B8-EFB3-412E-A3D0-081B19E83708Q35805508-61615613-2CE7-43D1-A5F7-3976ECE9F92EQ35858395-684803A4-4116-4DB7-8528-223398691770Q36433403-D3159924-4E94-485B-9BC1-7526CF912068Q36581469-FA688FC5-9E2E-44CA-8A0A-A438C3BE755CQ36687678-20E9E38E-35E0-4DF3-A18A-ECEDFCD866FAQ36849912-5B95BBF5-8CED-413E-BAB7-B2A69020B39BQ36978703-25DD18EA-4A3C-449B-BB8E-29547E232997Q37118791-C504D1B8-5773-4B03-9508-E2BCB446BF74Q37235560-CD89BF30-9265-4309-9B2B-7C5B9D0992E5Q37482022-389AFA5D-FECE-4FC4-BFDE-54918F4B8ECDQ37625242-FAF3A427-7616-46AE-A283-10FC2D1DEC26Q38647896-97B9BC05-73C1-4C08-84CD-C27AC9758D4DQ38883101-F102D6BE-8D5D-4B75-9F99-58BFAF3F8D9BQ39031223-906B0955-0328-4F93-BE7A-D5416EBFD256Q39980615-2776E32A-85D7-4D4B-B3BA-8758A1126500Q40529321-45B18BD3-38DC-4975-B898-1047DE310DFAQ40977071-EED51ECA-C54E-47AB-898B-1D1CF29D58BCQ44748014-223C3E40-62F0-4906-ACF2-7D767CE9E565Q47117659-AF17E258-4355-419E-9F56-14583B14C071Q50791604-A20424ED-F58C-4735-B8D0-42F90E5D510BQ55693698-4C486704-ADBB-44DB-8DBB-15D03AD0C0A5Q57144951-AA0DAA3D-CF4E-40E8-AE34-6B9D76618B15Q58775350-62D05DED-02E4-4A9B-B0A8-9B30DF1E3823
P2860
Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Eighteen insulin-like growth f ...... of prostate and breast cancer
@ast
Eighteen insulin-like growth f ...... of prostate and breast cancer
@en
Eighteen insulin-like growth f ...... of prostate and breast cancer
@nl
type
label
Eighteen insulin-like growth f ...... of prostate and breast cancer
@ast
Eighteen insulin-like growth f ...... of prostate and breast cancer
@en
Eighteen insulin-like growth f ...... of prostate and breast cancer
@nl
prefLabel
Eighteen insulin-like growth f ...... of prostate and breast cancer
@ast
Eighteen insulin-like growth f ...... of prostate and breast cancer
@en
Eighteen insulin-like growth f ...... of prostate and breast cancer
@nl
P2093
P2860
P50
P1476
Eighteen insulin-like growth f ...... of prostate and breast cancer
@en
P2093
Christine D Berg
Daniel O Stram
Fredrick R Schumacher
Gilles Thomas
J Michael Gaziano
Laudina Rodriguez
Laurence N Kolonel
P2860
P304
P356
10.1158/1055-9965.EPI-10-0507
P50
P577
2010-09-01T00:00:00Z